TWO SIGMA ADVISERS, LP - ADVERUM BIOTECHNOLOGIES INC ownership

ADVERUM BIOTECHNOLOGIES INC's ticker is ADVM and the CUSIP is 00773U108. A total of 97 filers reported holding ADVERUM BIOTECHNOLOGIES INC in Q1 2018. The put-call ratio across all filers is 0.20 and the average weighting 0.1%.

Quarter-by-quarter ownership
TWO SIGMA ADVISERS, LP ownership history of ADVERUM BIOTECHNOLOGIES INC
ValueSharesWeighting
Q3 2023$739,050
+8.8%
492,700
+15.3%
0.00%0.0%
Q2 2023$679,248
+40.1%
427,200
-36.8%
0.00%
+100.0%
Q1 2023$484,952
+14.5%
675,985
-7.5%
0.00%0.0%
Q4 2022$423,441
-57.6%
730,700
-30.5%
0.00%
-66.7%
Q3 2022$999,000
-44.7%
1,051,800
-30.1%
0.00%
-40.0%
Q2 2022$1,806,000
-8.3%
1,504,600
+0.1%
0.01%0.0%
Q1 2022$1,969,000
-41.1%
1,503,300
-20.9%
0.01%
-37.5%
Q4 2021$3,344,000
-12.8%
1,899,800
+7.5%
0.01%
-20.0%
Q3 2021$3,834,000
+12.3%
1,766,900
+81.2%
0.01%
+11.1%
Q2 2021$3,413,000
-61.3%
975,200
+9.0%
0.01%
-62.5%
Q1 2021$8,824,000
-12.6%
894,900
-3.9%
0.02%
-11.1%
Q4 2020$10,100,000
+6.8%
931,700
+1.5%
0.03%0.0%
Q3 2020$9,457,000
+3807.9%
918,200
+7815.5%
0.03%
+2600.0%
Q2 2020$242,000
+45.8%
11,600
-31.8%
0.00%0.0%
Q1 2020$166,000
-20.6%
17,000
-6.1%
0.00%
Q4 2019$209,000
-76.7%
18,100
-76.0%
0.00%
-100.0%
Q2 2019$897,000
+14.3%
75,400
-49.7%
0.00%0.0%
Q1 2019$785,000
+6.9%
149,900
-35.6%
0.00%0.0%
Q4 2018$734,000
-43.2%
232,900
+9.0%
0.00%
-33.3%
Q3 2018$1,293,000
+10.5%
213,700
-3.2%
0.00%0.0%
Q2 2018$1,170,000
+57.9%
220,800
+72.9%
0.00%
+50.0%
Q1 2018$741,000
+214.0%
127,700
+89.2%
0.00%
+100.0%
Q4 2017$236,000
+68.6%
67,500
+52.7%
0.00%0.0%
Q2 2016$140,00044,2000.00%
Other shareholders
ADVERUM BIOTECHNOLOGIES INC shareholders Q1 2018
NameSharesValueWeighting ↓
Sonic Fund II, L.P. 4,112,355$40,178,00034.81%
Versant Venture Management, LLC 7,068,233$69,056,636,00018.94%
ACUTA CAPITAL PARTNERS, LLC 1,704,500$16,653,0008.07%
Soleus Capital Management, L.P. 313,900$3,067,0003.57%
Ghost Tree Capital, LLC 1,305,500$12,755,0003.38%
SAN FRANCISCO SENTRY INVESTMENT GROUP (CA) 480,000$4,690,0002.97%
RTW INVESTMENTS, LP 6,631,627$64,791,0002.79%
VR Adviser, LLC 994,381$9,715,0002.63%
Avoro Capital Advisors LLC 7,150,000$69,856,0002.36%
RA Capital Management 7,272,714$71,054,0002.24%
View complete list of ADVERUM BIOTECHNOLOGIES INC shareholders